EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Development of a shared decision-making tool for gene therapy in hemophilia A in Italy

Giovanni Di Minno, Sarah Bigi, Serena Barello, Enrico Ferri Grazzi, Marco Follino, Maria Francesca Mansueto, Mariasanta Napolitano, Rita Carlotta Santoro, Giancarlo Castaman

Bleeding, Thrombosis and Vascular Biology · 22.06.2026 · 5 (2)

DOI: 10.4081/btvb.2026.426 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bleeding, Thrombosis and Vascular Biology, online erschienen am 22.06.2026. Verfasst von Giovanni Di Minno und 8 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gene therapy offers a transformative treatment option for hemophilia A (HA) by restoring endogenous factor VIII production. Shared decision-making (SDM) is a collaborative process that allows patients and clinicians to weigh the risks and benefits of complex treatment options such as gene therapy. However, no SDM tools exist for the specific needs of Italian persons with HA. Materials and Methods: An Expert Advisory Board comprising nine experts (including hematologists, a psychologist, a methodology expert, a linguist and patient advocacy group representatives) met three times between March and July 2024 to discuss gene therapy for HA in Italy, and develop an SDM tool to determine the suitability of gene therapy for HA.

Results

The resulting modular SDM tool allows for structured interactions between clinicians and patients, while remaining sensitive to each patient’s level of readiness and understanding. The tool includes three components: Role Definition, Agenda Alignment, and Intention Setting, with supporting materials to guide patient-clinician dialogue and various resources (questionnaires, brochures, and visual aids).

Conclusions

Despite requiring confirmation in further studies, this SDM tool may represent a useful component of patient-centered care for HA in the Italian healthcare setting.

Zitieren

APA

Minno, G. D., Bigi, S., Barello, S., Grazzi, E. F., Follino, M., Mansueto, M. F., Napolitano, M., Santoro, R. C., & Castaman, G. (2026). Development of a shared decision-making tool for gene therapy in hemophilia A in Italy. Bleeding, Thrombosis and Vascular Biology, 5(2). https://doi.org/10.4081/btvb.2026.426

Vancouver

Minno GD, Bigi S, Barello S, Grazzi EF, Follino M, Mansueto MF, et al. Development of a shared decision-making tool for gene therapy in hemophilia A in Italy. Bleeding, Thrombosis and Vascular Biology. 2026;5(2). doi:10.4081/btvb.2026.426

BibTeX
@article{Minno2026,
  author = {Minno, Giovanni Di and Bigi, Sarah and Barello, Serena and Grazzi, Enrico Ferri and Follino, Marco and Mansueto, Maria Francesca and Napolitano, Mariasanta and Santoro, Rita Carlotta and Castaman, Giancarlo},
  title = {Development of a shared decision-making tool for gene therapy in hemophilia A in Italy},
  journal = {Bleeding, Thrombosis and Vascular Biology},
  year = {2026},
  volume = {5},
  number = {2},
  doi = {10.4081/btvb.2026.426}
}
Kostenlos starten →